CORRECTION follows: “Of 1566 patients, 1195 with prostate-specific antigen levels of 0.1 to 0.5ng/mLreceivedESRTand371patientswithprostate-specificantigenlevelslower Data Presentation Error in Results Paragraph of Abstract: In the Original Inves- than 0.1 ng/mL received ART.” This article has been corrected online. tigation titled “Comparison Between Adjuvant and Early-Salvage Postprostatec- tomy Radiotherapy for Prostate Cancer With Adverse Pathological Features,” 1. Hwang WL, Tendulkar RD, Niemierko D, et al. Comparison between adjuvant published online January 25, 2018, there was an error in the data presented in and early-salvage postprostatectomy radiotherapy for prostate cancer with the Results paragraph of the Abstract. In the first sentence of that paragraph, the adverse pathological features [published online January 25, 2018]. JAMA Oncol. ranges of prostate-specific antigen levels were reversed. It should read as doi:10.1001/jamaoncol.2017.5230 jamaoncology.com (Reprinted) JAMA Oncology Published online February 22, 2018 E1 © 2018 American Medical Association. All rights reserved.
JAMA Oncology – American Medical Association
Published: May 22, 2018
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera